AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 154 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $4,921,000 | +22.9% | 143,086 | +6.7% | 0.01% | 0.0% |
| Q3 2014 | $4,003,000 | +52.0% | 134,082 | +2.1% | 0.01% | +75.0% |
| Q2 2014 | $2,634,000 | -26.4% | 131,289 | -0.3% | 0.00% | -33.3% |
| Q1 2014 | $3,579,000 | +35.7% | 131,667 | +3.6% | 0.01% | +20.0% |
| Q4 2013 | $2,637,000 | +19.1% | 127,124 | +3.7% | 0.01% | 0.0% |
| Q3 2013 | $2,215,000 | +12.7% | 122,617 | +6.3% | 0.01% | +25.0% |
| Q2 2013 | $1,966,000 | – | 115,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,883,879 | $101,243,000 | 9.44% |
| Tamarack Capital Management, LLC | 1,250,000 | $25,913,000 | 6.14% |
| Healthcare Value Capital, LLC | 334,481 | $6,934,000 | 5.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,113,385 | $85,270,000 | 4.42% |
| KING INVESTMENT ADVISORS INC/TX | 312,890 | $6,486,000 | 2.96% |
| Broadfin Capital, LLC | 961,100 | $19,924,000 | 2.63% |
| SECTOR GAMMA AS | 462,504 | $9,588,000 | 2.59% |
| TAMRO Capital Partners LLC | 1,898,717 | $39,360,000 | 1.62% |
| Elk Creek Partners, LLC | 84,090 | $1,743,000 | 1.25% |
| Artal Group S.A. | 1,500,000 | $31,095,000 | 1.12% |